Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Dec 11, 2006

DNA2.0 Receives NSF Grant for Synthetic Gene Design

  • DNA2.0 was awarded an SBIR grant from the NSF to further expand its work in protein expression and to develop an automated, multivariate machine learning algorithm for optimizing synthetic gene design.

    DNA2.0 is working to identify critical variables and understand their impact on protein expression. A multivariate array of genes will be synthesized in DNA2.0's gene manufacturing facility and then tested. The resulting multidimensional sequence-expression landscape will be modeled and the resulting algorithm will be incorporated into Gene Designer™, a freely available software for the design of synthetic genes.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »